Experimental peptide treatment could triple survival rates in severe blood loss cases
Researchers at the Hebrew University of Jerusalem and the IDF Medical Corps have discovered a promising new therapeutic approach to treating hemorrhagic shock, a life-threatening condition caused by severe blood…